Cargando…

Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?

Detalles Bibliográficos
Autores principales: Ashina, Messoud, Martelletti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940973/
https://www.ncbi.nlm.nih.gov/pubmed/29740710
http://dx.doi.org/10.1186/s10194-018-0860-4
_version_ 1783321197556006912
author Ashina, Messoud
Martelletti, Paolo
author_facet Ashina, Messoud
Martelletti, Paolo
author_sort Ashina, Messoud
collection PubMed
description
format Online
Article
Text
id pubmed-5940973
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-59409732018-05-14 Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches? Ashina, Messoud Martelletti, Paolo J Headache Pain Editorial Springer Milan 2018-05-08 /pmc/articles/PMC5940973/ /pubmed/29740710 http://dx.doi.org/10.1186/s10194-018-0860-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Editorial
Ashina, Messoud
Martelletti, Paolo
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
title Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
title_full Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
title_fullStr Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
title_full_unstemmed Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
title_short Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
title_sort pituitary adenylate-cyclase-activating polypeptide (pacap): another novel target for treatment of primary headaches?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940973/
https://www.ncbi.nlm.nih.gov/pubmed/29740710
http://dx.doi.org/10.1186/s10194-018-0860-4
work_keys_str_mv AT ashinamessoud pituitaryadenylatecyclaseactivatingpolypeptidepacapanothernoveltargetfortreatmentofprimaryheadaches
AT martellettipaolo pituitaryadenylatecyclaseactivatingpolypeptidepacapanothernoveltargetfortreatmentofprimaryheadaches